Compile Data Set for Download or QSAR
Report error Found 175 Enz. Inhib. hit(s) with all data for entry = 1574
TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331621(US9725459, 86 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  1nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331540(US9725459, 3 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-o...)
Affinity DataKi:  3nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331622(US9725459, 87 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  4nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331568(US9725459, 33 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  4nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331539(US9725459, 2 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-o...)
Affinity DataKi:  5nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331620(US9725459, 85 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  5nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331566(US9725459, 31 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  5nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331591(US9725459, 56 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  6nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin S(Human)
Grunenthal

US Patent
LigandPNGBDBM331620(US9725459, 85 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  6nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin S(Human)
Grunenthal

US Patent
LigandPNGBDBM331609(US9725459, 74 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  7nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331601(US9725459, 66 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  7nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331618(US9725459, 83 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  7nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331586(US9725459, 51 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  7nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331580(US9725459, 45 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  8nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331604(US9725459, 69 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  8nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331606(US9725459, 71 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  8nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331564(US9725459, 29 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  9nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331581(US9725459, 46 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  9nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331584(US9725459, 49 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  9nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331617(US9725459, 82 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  9nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin S(Human)
Grunenthal

US Patent
LigandPNGBDBM331604(US9725459, 69 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  9nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331565(US9725459, 30 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  10nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331625(US9725459, 90 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  10nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331543(US9725459, 6 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-o...)
Affinity DataKi:  11nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331616(US9725459, 81 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  11nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331585(US9725459, 50 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  11nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331575(US9725459, 40 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  12nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331544(US9725459, 7 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-o...)
Affinity DataKi:  12nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin S(Human)
Grunenthal

US Patent
LigandPNGBDBM331624(US9725459, 89 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  13nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin S(Human)
Grunenthal

US Patent
LigandPNGBDBM331608(US9725459, 73 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  13nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331552(US9725459, 16 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  13nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331541(US9725459, 4 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-o...)
Affinity DataKi:  14nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331583(US9725459, 48 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  14nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331577(US9725459, 42 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  14nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331538(US9725459, 1 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-o...)
Affinity DataKi:  14nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331563(US9725459, 28 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  14nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331587(US9725459, 52 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  14nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331572(US9725459, 37 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  15nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331608(US9725459, 73 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  15nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331579(US9725459, 44 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  15nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin S(Human)
Grunenthal

US Patent
LigandPNGBDBM331613(US9725459, 78 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  16nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331615(US9725459, 80 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  16nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331569(US9725459, 34 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  16nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331553(US9725459, 17 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  16nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331570(US9725459, 35 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  16nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331619(US9725459, 84 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  16nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331545(US9725459, 8 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-o...)
Affinity DataKi:  17nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331623(US9725459, 88 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  18nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331624(US9725459, 89 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  18nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

TargetCathepsin K(Human)
Grunenthal

US Patent
LigandPNGBDBM331610(US9725459, 75 | N-((S)-2-((3aS,6S,6aS)-6-chloro-3-...)
Affinity DataKi:  18nMAssay Description:Recombinant human cathepsins (CatS, CatK, CatL) were purchased from a Enzo Life Sciences. All assays were carried out in 96-well format using a buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2019
Entry Details
US Patent

Displayed 1 to 50 (of 175 total ) | Next | Last >>
Jump to: